| Ytd | -58.37% | |
| 1y | -84.86% |
| Open | 6.82 | Prev Close | 6.89 | Low | 6.80 | High | 6.87 | Mkt Cap | 44.73M |
| Vol | 5.58K | Avg Vol | 17.53K | EPS | -6.29 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.18 | Short Ratio | 0.09 | Inst. Own | 3.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 6.29 | 200-d Avg | 11.04 | 1yr Est | 4.20 |
TVGN News
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced th
WARREN, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (
WARREN, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced the
William Keane Appointed Interim Head of Initiative, Evaluating Potential Management Services Organiz
WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (N
WARREN, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (N
Tevogen highlights improved operating performance, disciplined capital allocation, pipeline growth,
Tevogen Bio Holdings (NASDAQ:TVGN) reported quarterly losses of $(1.61) per share which beat the ana
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced tha
WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (N
WARREN, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
Potential transaction expected to add $20M+ in revenue and support double-digit growth, further stre
Potential transaction expected to add $20M+ in revenue and support double-digit growth, further stre
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) received written no
WARREN, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
Tevogen Bio (NASDAQ: TVGN - Get Free Report) will likely be releasing its results before the market
WARREN, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
Tevogen highlights capital discipline, minimal share use, strong insider ownership, and potential ac
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced per
WARREN, N.J., March 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
WARREN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-
Leadership Designations:Digital Health: Arpita Patel and Wojtek StobinskiGenerics: Sadiq Khan and Da
WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
Tevogen Bio Holdings (NASDAQ: TVGN) shares are wobbling on Friday as the company is advancing its ge
Tevogen stock swings after Apozeal acquisition talks and a 50-for-1 reverse split as TVGN trades nea
Dow Jones falls 500 points on Friday, Marvell Technology shares jump 18.4%, other stocks recording g
If consummated, the potential acquisition of Apozeal could provide Tevogen with an established gener
WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced tha
WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”)
D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy an
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced tha
Tevogen ("Tevogen Bio Holdings Inc.") (NASDAQ:TVGN) today announced that it has entered into
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced tha
Jan. 12, 2026, San Francisco. Issued from the J.P. Morgan Healthcare ConferenceWARREN, N.J., Jan. 12
Pipeline Expansion Across Multiple Indications:Building on its SARS-CoV-2 proof-of-concept clinical
D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy an
This milestone expands patient eligibility through multi-HLA targetingBuilds on completed TVGN 489 t